SELECTED IMPORTANT SAFETY INFORMATION
Some people who have taken medicine like ATRIPLA have developed
the following:

A serious condition called lactic acidosis (buildup of an acid in the blood)

Serious liver problems called hepatotoxicity

A "flare-up" of hepatitis. If you have HIV-1 and hepatitis B virus (HBV) infection and you stop taking ATRIPLA, you may get a "flare-up" (a sudden worsening) of your hepatitis

Please click here for additional Important Safety Information, including Boxed WARNINGS.

Search:

information for healthcare professionals

Questions to Ask Your Doctor

The following are some questions that may be helpful to you when discussing ATRIPLA with your doctor. Together, you can decide which treatment regimen might work best for you. Always discuss with your doctor all medications and supplements that you take. It’s important to be honest and specific with your doctor to get the best possible results from your treatment.

1. Is ATRIPLA an appropriate regimen for me?

2. How will we know if ATRIPLA is working?

3. Is taking ATRIPLA the same as taking SUSTIVA^® (efavirenz) and
TRUVADA^® (emtricitabine/tenofovir disoproxil fumarate)?

4. If I take ATRIPLA, will I have to take any other HIV meds?

5. What are the possible side effects of ATRIPLA?

6. If I experience side effects, what should I do?

7. What if I forget to take a dose of ATRIPLA?

8. How can I get help paying for my HIV medications?

9. Should I take ATRIPLA if I am pregnant or nursing?

ATRIPLA does not cure HIV-1 and has not been shown to prevent passing HIV-1 to others.

Ask your doctor if ATRIPLA is right for you, and see your healthcare provider regularly. Individual results may vary.

Please click here for Important Safety Information, including information on lactic acidosis, serious liver problems, and flare-ups of hepatitis B virus (HBV).

Please send me information and updates.

Find an HIV/AIDS Service Organization near you.

Distance to search:

Enter your ZIP code:

Site Map | Contact Us | Privacy Policy | Terms of Use | Unsubscribe

Click here for ATRIPLA Full Prescribing Information.

©2010 Bristol-Myers Squibb & Gilead Sciences, LLC. All rights reserved. ATRIPLA and ATRIPLA Peer Advocate Network are trademarks of Bristol-Myers Squibb & Gilead Sciences, LLC. EMTRIVA, TRUVADA, and VIREAD are trademarks of Gilead Sciences, Inc. SUSTIVA, REYATAZ, VIDEX, VIDEX EC, and Pravachol are registered trademarks of Bristol-Myers Squibb and its affiliated companies. All other trademarks are owned by third parties.

Patient models are used on this Web site. The information on this site is intended for residents of the United States who are 18 years of age or older. The content of this site is protected under applicable copyright and trademarks law.

This site may contain, from time to time, information related to various health, medical and fitness conditions, and their treatment. Such information is not meant to be a substitute for the advice provided by a physician or other medical professional. You should not use the information contained herein for diagnosing a health or fitness problem or disease. You should always consult a physician and/or a healthcare provider.

Your use of this information is subject to the terms and conditions of our Terms of Use and Privacy Policy.

697US10AD00801/TR4402 05/10